A Study of 2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069)
NCT00835380
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
80
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis A Virus Infection
Interventions
BIOLOGICAL:
Hepatitis A Vaccine, Purified Inactivated (VAQTA™)
Sponsor
Merck Sharp & Dohme LLC